Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Predictors of burden and depression among caregivers of relapsing-remitting MS patients in Spain: MS Feeling study.
Differentiation of bone marrow stromal cells into schwann-like cells using dihydrotestosterone combined with a classical induction method.
Selective depletion of CD11c(+) CD11b(+) dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE.
Tolerogenic Vaccination with MOG/VitD Overcomes Aggravating Effect of C. albicans in Experimental Encephalomyelitis.
The APOSTEL recommendations for reporting quantitative optical coherence tomography studies.
Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.
Regulation of Oligodendrocyte Differentiation and Myelination by Nuclear Receptors: Role in Neurodegenerative Disorders.
Sphingosine 1-phosphate signaling in astrocytes: Implications for progressive multiple sclerosis.
A mouse model for testing remyelinating therapies.
Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies.
β-defensin-2 is a responsive biomarker of IL-17A-driven skin pathology in psoriasis.
Patient Management Problem-Preferred Responses.
Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation.
Nogo-A does not inhibit retinal axon regeneration in the lizard, Gallotia galloti.
Role of the α7 nicotinic acetylcholine receptor and RIC-3 in the cholinergic anti-inflammatory pathway.
Neurodegeneration in MS and NMO: The Eye and the Blood.
Overview and diagnosis of multiple sclerosis.
Lubrini et al.'s study, "The contribution of depressive symptoms to slowness of information processing in relapsing remitting multiple sclerosis".
Rhabdomyolysis following interferon-beta treatment in a patient with multiple sclerosis - A case report.
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod.
Thermal patterns in zoster.
Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis.
Relevance of biomarkers in disease progression in multiple sclerosis.
Intra-CNS activation by antigen-specific T lymphocytes in experimental autoimmune encephalomyelitis.
Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ).
Pages
« first
‹ previous
…
707
708
709
710
711
712
713
714
715
…
next ›
last »